PQF-21661-95500
4 vaccinations
5 coded responses
19 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 220 / VA
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-14
Registered in v-safe
- 2021-03-14
- 2021-03-15
- 2021-03-22
-
2021-03-29
Dose 2 — Pfizer-BioNTech
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: Fair · Headache, Fatigue or tirednessFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: GoodFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
- 2021-04-12
- 2021-04-21
-
2021-05-05
Survey response — day 35, dose 2MedDRA: Cough — Feeling: FairFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-10
-
2021-09-27
Survey response — 6 months, dose 2MedDRA: Cough, Nasal congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Nasal congestion, coughMedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Dose 3 — Pfizer-BioNTech
- 2022-03-29
-
2022-09-27
Dose 4 — Moderna
- 2022-10-28
- 2022-11-01
- 2022-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
| 4 | 2022-09-27 | Moderna | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Nasal congestion
Systemic reaction (other): Nasal congestion
Systemic reaction (other): Nasal congestion
Release 8 — day 35, dose 2
Symptoms: Cough
Release 9 — 6 months, dose 2
Symptoms: Nasal congestion, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release